Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Harris

Showing results (21-30 of 682) with videos related to

Pageof 69
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
What does BCL-2 mean in solid tumours--friend or foe?A L Harris
Lancet (London, England)|November 6, 1993
Gene amplification: a target for cancer therapyA L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Epidermal growth factor receptor in human breast cancerA L Harris
Lancet (London, England)|June 10, 1998
Are angiostatin and endostatin cures for cancer?A L Harris
Breast Cancer Research and Treatment|January 1, 1985
Could aminoglutethimide replace adrenalectomy?A L Harris
British Medical Journal|May 6, 1978
Leukostasis associated with blood transfusion in acute myeloid leukaemiaA L Harris
The Oncologist|May 10, 2000
von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapyA L Harris
Breast Cancer Research and Treatment|January 1, 1994
What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer?A L Harris
The Journal of Pathology|September 1, 1990
Mutant p53--the commonest genetic abnormality in human cancer?A L Harris
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|October 1, 1990
The epidermal growth factor receptor as a target for therapyA L Harris
Pageof 69

Showing results (21-30 of 682) with videos related to

Sort By:
Pageof 69
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1994
What does BCL-2 mean in solid tumours--friend or foe?A L Harris
Lancet (London, England)|November 6, 1993
Gene amplification: a target for cancer therapyA L Harris
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Epidermal growth factor receptor in human breast cancerA L Harris
Lancet (London, England)|June 10, 1998
Are angiostatin and endostatin cures for cancer?A L Harris
Breast Cancer Research and Treatment|January 1, 1985
Could aminoglutethimide replace adrenalectomy?A L Harris
British Medical Journal|May 6, 1978
Leukostasis associated with blood transfusion in acute myeloid leukaemiaA L Harris
The Oncologist|May 10, 2000
von Hippel-Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapyA L Harris
Breast Cancer Research and Treatment|January 1, 1994
What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer?A L Harris
The Journal of Pathology|September 1, 1990
Mutant p53--the commonest genetic abnormality in human cancer?A L Harris
Cancer Cells (Cold Spring Harbor, N.Y. : 1989)|October 1, 1990
The epidermal growth factor receptor as a target for therapyA L Harris
Pageof 69